What does argenx do?
argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer.
How does Efgartigimod work?
Vyvgart works by blocking FcRn, thereby increasing the rate at which IgG antibodies, including those driving MG, are broken down. By lowering the levels of disease-driving antibodies, the therapy is expected to ease MG symptoms.
Is Efgartigimod a monoclonal antibody?
Efgartigimod, currently in phase 3 trials for generalized myasthenia gravis (MG) and immune thrombocytopenia (ITP), is a monoclonal IgG1 Fc fragment that has been mutated at 5 residues to increase its affinity for FcRn at both physiologic and acidic pH.
Where is Argenx located?
argenx is located in Ghent, Belgium, Boston, Massachusetts and Tokyo, Japan.
How big is argenx?
Rowe Price Health Sciences fund (PRHSX), has a possible big one up his sleeve: Argenx (ARGX), a Dutch biotech with a substantial $15.2 billion market value and no products on the market yet.
Is argenx a good place to work?
argenx Reviews FAQs Is argenx a good company to work for? argenx has an overall rating of 4 out of 5, based on over 6 reviews left anonymously by employees. 100% of employees would recommend working at argenx to a friend and 51% have a positive outlook for the business.
Who makes Efgartigimod?
argenx is developing efgartigimod for six other autoimmune diseases where IgG antibodies are involved, including the blood disorder immune thrombocytopenia and the skin blistering disorder pemphigus vulgaris.
What does IVIg do for myasthenia gravis?
IVIg works by altering your immune system and neutralizing or destroying damaging antibodies. This type of treatment is used for patients with severe or rapidly worsening symptoms of MG.
Is Argenx a good company?
How big is Argenx?
What is argenx?
At argenx, we’ve created an antibody innovation ecosystem where pioneering scientists and antibody engineers work side-by-side to accelerate the discovery of novel targets, disease pathways and differentiated therapeutic antibodies. argenx comes from the story of the Argonauts – we want to achieve the unthinkable together.
What is the antibody innovation ecosystem at argenx?
At argenx, we’ve created an antibody innovation ecosystem where pioneering scientists and antibody engineers work side-by-side to accelerate the discovery of novel targets, disease pathways and differentiated therapeutic antibodies.
What is argx-118 antibody?
ARGX-118 was designed as a highly differentiated antibody against Galectin-10, the protein of Charcot-Leyden crystals, which are implicated as a major contributor to severe asthma and to the persistence of mucus plugs.
What are arGEN-X’s technical breakthroughs?
Tim Van Hauwermeiren, the CEO of arGEN-X, will highlight a series of important technical breakthroughs during his presentation, demonstrating the power of the Company’s SIMPLE Antibody™ platform to deliver multiple, diverse, ultra-potent functional antibodies that are able to blanket any target, regardless of its complexity.